Prabakar Kumar Rao MD
Retinal Disease, Uveitis, Ocular Oncology
Professor and Faculty Clinical Director, John F Hardesty MD Department of Ophthalmology & Visual Sciences, Washington University in St. Louis School of Medicine
Join to View Full Profile
4901 Forest Park AveSaint Louis, MO 63108
Phone+1 314-362-3937
Fax+1 314-362-3725
Dr. Rao is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Washington University in St. LouisMBA, 2017 - 2018
Washington University/B-JH/SLCH ConsortiumFellowship, Surgical Retina and Vitreous, 1999 - 2001
Medical College of Wisconsin Affiliated HospitalsResidency, Ophthalmology, 1996 - 1999- Aurora Health CareInternship, Transitional Year, 1995 - 1996
Keck School of Medicine of the University of Southern CaliforniaClass of 1995
Certifications & Licensure
AZ State Medical License 2003 - 2026
CA State Medical License 2004 - 2026
IL State Medical License 2001 - 2026
MO State Medical License 1999 - 2026
WI State Medical License 1996 - 2017
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012
Publications & Presentations
PubMed
- Crizanlizumab for retinal vasculopathy with cerebral leukoencephalopathy in a phase II clinical study.Wilson X Wang, Dan Spiegelman, P Kumar Rao, Rennie L Rhee, Andria L Ford
The Journal of Clinical Investigation. 2024-12-16 - 1 citationsCrizanlizumab for retinal vasculopathy with cerebral leukoencephalopathy in a phase II clinical study.Wilson X Wang, Dan Spiegelman, P Kumar Rao, Rennie L Rhee, Andria L Ford
The Journal of Clinical Investigation. 2024-05-07 - 1 citationsMultimodal Structural and Functional Characterization of Retinal Vasculopathy with Cerebral Leukoencephalopathy.Wilson X Wang, Aaditya V Shah, Brent Bruck, Gregory Van Stavern, P Kumar Rao
Ophthalmology. Retina. 2024-04-01
Press Mentions
Repurposed Drug May Help Stabilize Vision in Rare DiseaseJune 17th, 2024- Repurposed Drug May Help Stabilize Vision in Rare DiseaseJune 17th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
